These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Current management of intermittent claudication: the role of pharmacological and nonpharmacological symptom-directed therapies. Mangiafico RA; Fiore CE Curr Vasc Pharmacol; 2009 Jul; 7(3):394-413. PubMed ID: 19601864 [TBL] [Abstract][Full Text] [Related]
23. Clinical manifestation of atherosclerotic peripheral arterial disease and the role of cilostazol in treatment of intermittent claudication. Grouse JR; Allan MC; Elam MB J Clin Pharmacol; 2002 Dec; 42(12):1291-8. PubMed ID: 12463722 [TBL] [Abstract][Full Text] [Related]
24. What constitutes best medical therapy for peripheral arterial disease? Burns P; Lima E; Bradbury AW Eur J Vasc Endovasc Surg; 2002 Jul; 24(1):6-12. PubMed ID: 12127842 [TBL] [Abstract][Full Text] [Related]
25. Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons". Paraskevas KI J Vasc Surg; 2008 Sep; 48(3):776-7; author reply 777. PubMed ID: 18727983 [No Abstract] [Full Text] [Related]
26. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization. Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402 [TBL] [Abstract][Full Text] [Related]
27. Optimal medical management of peripheral arterial disease. Rice TW; Lumsden AB Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725 [TBL] [Abstract][Full Text] [Related]
28. Peripheral artery disease: current insight into the disease and its diagnosis and management. Olin JW; Sealove BA Mayo Clin Proc; 2010 Jul; 85(7):678-92. PubMed ID: 20592174 [TBL] [Abstract][Full Text] [Related]
35. Antiplatelet and antithrombotic treatment of patients with peripheral arterial disease. Poredos P; Jezovnik MK Int Angiol; 2010 Feb; 29(1):20-6. PubMed ID: 20224527 [TBL] [Abstract][Full Text] [Related]
36. The role of tobacco cessation, antiplatelet and lipid-lowering therapies in the treatment of peripheral arterial disease. Hirsch AT; Treat-Jacobson D; Lando HA; Hatsukami DK Vasc Med; 1997; 2(3):243-51. PubMed ID: 9546975 [TBL] [Abstract][Full Text] [Related]
37. Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies. Momsen AH; Jensen MB; Norager CB; Madsen MR; Vestersgaard-Andersen T; Lindholt JS Eur J Vasc Endovasc Surg; 2009 Oct; 38(4):463-74. PubMed ID: 19586783 [TBL] [Abstract][Full Text] [Related]
38. Is aspirin still the drug of choice for management of patients with peripheral arterial disease? Poredos P; Jezovnik MK Vasa; 2013 Mar; 42(2):88-95. PubMed ID: 23485835 [TBL] [Abstract][Full Text] [Related]
39. [The future prospects of antithrombotic therapy in peripheral vasculopathy]. Violi F; Loffredo L; Annessi M Ann Ital Med Int; 1999; 14(3):185-91. PubMed ID: 10566184 [TBL] [Abstract][Full Text] [Related]
40. Peripheral arterial disease in the elderly: recognition and management. Aronow H Am J Cardiovasc Drugs; 2008; 8(6):353-64. PubMed ID: 19159122 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]